Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

India Globalization Capital, Inc. (NYSE: IGC) Reports Promising Progress of Cannabis-Based Alzheimer’s Drug Candidate

IGC is the only publicly traded cannabis stock with patent filings for treating Alzheimer’s disease Company has a first-mover advantage in phytocannabinoid-based combination therapy Alzheimer’s is America’s most expensive disease, costing the country an estimated $259 billion in 2017 It is considered America’s most expensive disease, projected to cost an estimated $259 billion in the […]

ProBility Media Corp. (PBYA) Professional e-Learning and Training Addressing Rising Demand for Skilled Labor

ProBility now offers leading vocational educational materials in 60+ fields, including the electrical, construction, plumbing and security industries An overwhelming majority of technical employers are struggling to find workers with the appropriate skills Technical high schools are simulating workplaces to prepare students for their careers in historically underprivileged areas Access to technology-based education resources is […]

AppSwarm, Inc. (SWRM) Targeting Revenues of $6-7 Million by FY2018

SWRM restructures as one company with two divisions, capitalizing on synergies between MediaPlay and Incubation and Acquisition Development Ron Brewer, CEO and director, forecasts significant revenue growth in FY2017, cites strong initial revenues in FY2016 New management team at SWRM, with extensive acquisition experience, is seasoned in growing emerging companies AppSwarm, Inc. (OTC: SWRM), under […]

InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Builds Moat around Proprietary Biosynthesis Technology

Proprietary biosynthesis process to produce cannabinoids Provisional patent application filed Cost-effective methodology to produce trace cannabinoids If you have any doubt that InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) is on the right track as it moves to protect its biosynthesis technology for cannabinoids, then a word from a famed figure may make you change […]

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) Oral CBD Product to Be Tested by the University of British Columbia

The University of British Columbia (UBC) will conduct a double-blind study of Lexaria’s TurboCBD™ oral ingestion product TurboCBD™ masks foul tastes, protects pharmaceutical ingredients during stomach passage and increases intestinal absorption by 5-10x The UBC study will include 24 volunteers and test their cognitive and cardiovascular function after single doses and after seven days of […]

LottoGopher Holdings, Inc. (OTCQB: LTTGF) (CSE: LOTO) (FRA: 2LG) Names William Shatner Company Spokesperson

The holding company, through its subsidiaries, operates in California and permits players to buy, manage their Lotto tickets online, and receive exclusive special lottery news Eyeing expansion in the U.S., LTTGF has hired legal contractor to begin due diligence process for launch into other states James Morel, president and CEO, said online site has been […]

ProBility Media Corp. (PBYA) Consolidating Skilled Trades Industries eLearning and Training Resources

Offering superior online training for small/medium-sized businesses, previously accessible to only larger companies Recent acquisitions and joint ventures have expanded ProBility’s offerings to include more products and cover more industries than ever before Company now includes Brown Technical Media Corp., Brown Technical Publications Inc., Brown Book Shop, Inc., National Electrical Wholesale Providers, W Marketing, One […]

 

Latest From Twitter

Follow us: @Buy_Stocks_Now

From Our Blog

India Globalization Capital, Inc. (NYSE: IGC) Reports Promising Progress of Cannabis-Based Alzheimer’s Drug Candidate

September 18, 2017

IGC is the only publicly traded cannabis stock with patent filings for treating Alzheimer’s disease Company has a first-mover advantage in phytocannabinoid-based combination therapy Alzheimer’s is America’s most expensive disease, costing the country an estimated $259 billion in 2017 It is considered America’s most expensive disease, projected to cost an estimated $259 billion in the […]

Rotate your device 90° to view site.